Title |
Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review
|
---|---|
Published in |
BMC Infectious Diseases, April 2007
|
DOI | 10.1186/1471-2334-7-24 |
Pubmed ID | |
Authors |
Monique A de Bruin, Lee W Riley |
Abstract |
Vancomycin resistant enterococcus (VRE) is a major cause of nosocomial infections in the United States and may be associated with greater morbidity, mortality, and healthcare costs than vancomycin-susceptible enterococcus. Current guidelines for the control of VRE include prudent use of vancomycin. While vancomycin exposure appears to be a risk factor for VRE acquisition in individual patients, the effect of vancomycin usage at the population level is not known. We conducted a systematic review to determine the impact of reducing vancomycin use through prescribing interventions on the prevalence and incidence of VRE colonization and infection in hospitals within the United States. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 1% |
Czechia | 1 | 1% |
Taiwan | 1 | 1% |
Unknown | 79 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 15 | 18% |
Researcher | 13 | 16% |
Other | 8 | 10% |
Student > Postgraduate | 7 | 9% |
Student > Ph. D. Student | 7 | 9% |
Other | 21 | 26% |
Unknown | 11 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 37 | 45% |
Agricultural and Biological Sciences | 7 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 7% |
Immunology and Microbiology | 4 | 5% |
Social Sciences | 3 | 4% |
Other | 12 | 15% |
Unknown | 13 | 16% |